:

AI FAILS INVESTMENT BANKING TEST, NONE CLIENT-READY

AI DESK1 MIN READ
SUN, APR 26, 2026

■ AI-SUMMARIZED FROM 1 SOURCE BELOW

A benchmark test of 500 investment bankers found that top AI models including GPT-5.4 and Claude Opus 4.6 produced no outputs suitable for client delivery. Despite the failures, over half the bankers said they would use AI results as a starting point.

The evaluation assessed how leading AI systems handle routine junior banker tasks. Results were consistently subpar, with outputs containing imprecision or factual errors that made them unsuitable for direct client use. The findings highlight a gap between AI capabilities and financial services requirements, where accuracy and reliability are paramount. Clients expect error-free analysis and recommendations. However, the test revealed partial utility. More than 50% of bankers indicated willingness to leverage AI outputs as drafts or initial frameworks, requiring human review and refinement before delivery. This middle ground suggests AI's near-term role in banking: augmenting analyst workflows rather than replacing junior-level work entirely. The benchmark demonstrates current models cannot yet fully automate entry-level investment banking tasks but may reduce manual labor when paired with human oversight.

■ SOURCES

The Decoder

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE AI DESK

Andon Market, a San Francisco retail boutique, operates as the first store managed entirely by an AI agent. The experiment uses Anthropic's Claude Sonnet 4.6 model to handle store operations.

JUST NOWAI Desk

A new survey reveals Claude's weekly active users in the US have significantly higher incomes than users of competing AI assistants like ChatGPT and Gemini.

2H AGOAI Desk

The inaugural World AI Film Festival (WAIFF) premiered in Cannes this week, showcasing AI-generated cinema while the prestigious Palme d'Or competition bans emerging technology from entries.

2H AGOAI Desk

OpenAI has launched a bug bounty program focused on GPT-5.5's biological research capabilities. The initiative aims to identify safety risks before the model's wider deployment.

5H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.